Compare RMD & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | EXPE |
|---|---|---|
| Founded | 1989 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 39.5B |
| IPO Year | 1996 | 2005 |
| Metric | RMD | EXPE |
|---|---|---|
| Price | $227.97 | $288.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 29 |
| Target Price | ★ $292.56 | $275.89 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.13% | 0.77% |
| EPS Growth | ★ 9.67 | 9.61 |
| EPS | ★ 10.43 | 7.05 |
| Revenue | $2,957,013,000.00 | ★ $14,733,000,000.00 |
| Revenue This Year | $10.60 | $10.35 |
| Revenue Next Year | $7.41 | $6.93 |
| P/E Ratio | ★ $22.00 | $41.57 |
| Revenue Growth | ★ 13.44 | 7.61 |
| 52 Week Low | $180.27 | $185.34 |
| 52 Week High | $284.87 | $342.00 |
| Indicator | RMD | EXPE |
|---|---|---|
| Relative Strength Index (RSI) | 55.85 | 46.30 |
| Support Level | $199.75 | $256.60 |
| Resistance Level | $233.75 | $298.11 |
| Average True Range (ATR) | 6.12 | 12.50 |
| MACD | -1.73 | -4.39 |
| Stochastic Oscillator | 51.28 | 39.28 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of 2025 sales), air tickets (3%), rental cars, cruises, in-destination, and other (9%), and advertising revenue (8%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.